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Abstract. Based on hypotheses concerning the role of stress in acute pancreatitis development, 
the experimental approach for the decrease stress damage via the use the compound with proven 
antistress/neuroleptic action was conducted. The study was aimed to discover 2-morpholino-
5-phenyl-6H-1,3,4-thiadiazine hydrobromide (compound L-17) therapeutic action in experimental 
acute pancreatitis. The experimental model used was the ligation model. The trial was carried out on 
50 male Wistar rats with average body weight 180–240 g. Histological picture of the pancreas was 
studied and biochemical and enzyme-immunoassays were carried out on the first and seventh days. 
The significant reduction in mortality on the background of L-17 compound administration was 
observed. While levels of all cytokines increased in induced experimental acute pancreatitis groups, 
the cytokine level rise was decreased when compound L-17 was administered. On the cellular level, 
the study revealed L-17’s ability to prevent granulocytosis and decrease granulocytes infiltration to 
inflammatory foci. The decrease in inflammatory reaction magnitude and prevention of abscess 
formation in experimental acute pancreatitis accompanied by sistemic inflamamtion was due to 
L-17’s ability to reduce neutrophilia and neutrophil entry into the injury zone. 
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Introduction
Acute pancreatitis (AP) caused approximately 275,000 hospi-
talizations in 2009 (more than a 2-fold increase since 1982), 
and it is the single most frequent gastrointestinal cause of 
hospital admissions in the United States (Peery et al. 2012). 
The reason for this is its diverse aetiology and the unpredict-
able course of the disease (Maleszka et al. 2017). The aetiol-
ogy, pathogenesis, and progression of acute pancreatitis are 
the subjects of numerous experimental and clinical studies 
(Tomaszewska et al. 2000). The aetiology of AP, apart from 
alcohol abuse and cholelithiasis, may also include a vascular 
component responsible for pancreatic ischaemia (Tomasze-
wska et al. 2000). However, the most frequent aetiology is 
cholelithiasis, which accounts for 30–60% of cases (Maleszka 
et al. 2017).
Despite the new understanding and developments in AP 
diagnosis, aetiology, and early and late management in the past 
decade, no specific effective treatment has been reported from 
clinical trials (Ceranowicz et al. 2008; Tenner et al. 2013). The 
pathophysiology of acute pancreatitis is still based on the 1998 
hypothesis of Rinderknecht that the effects occur on distant 
organs following the release of inflammatory mediators by 
activated immune cells in response to pancreatic tissue damage 
(Rinderknecht 1988; Ceranowicz et al. 2007). This pathophysi-
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ological approach suggests that activated leukocytes and the 
systemic release of cytokines play a key role in the conversion 
of local pancreatic injury into a systemic process (Banks et 
al. 1991; Brady et al. 1999). However, later observations that 
proinflammatory cytokine gene expression is not coupled to 
a specific form of injury but is instead observed in all forms 
suggest that those molecules constitute part of an intrinsic or 
innate stress response system (Mann 2003).
Furthermore, the secretion of TNF-α due to the action 
of various stressful stimuli has now been demonstrated in 
many cell types, including pancreatic acinar cells, and direct 
links between acute/chronic pancreatitis and stress reaction 
have been described in recent decades (Cosen-Binker et al. 
2003, 2004; Binker et al. 2010, 2014). Thus, it has been shown 
that AP induction following stress is more severe than in its 
absence and that pancreatitis itself acts as an even stronger 
and noxious stress generator than long-term animal restraint. 
Furthermore, Cosen-Binker et al. (2004) maintain that 
once severe AP is triggered and the inflammatory cascade 
unchained, added stress is essentially ‘adding more fuel to 
an already voracious fire’. 
With that, an experimental approach for decreased stress 
damage via the use of anaesthetics has been described (Cosen-
Binker et al. 2003). Treatment with an anaesthetic (lidocaine 
chlorhydrate) before triggering AP has been shown to decrease 
the severity of the disease. This was most likely due to the an-
aesthetic interrupting arc reflexes and rendering milder gastric 
lesions, and the effect was more pronounced when associ-
ated with adrenergic pathway blockage by phentolamine and 
propranolol antagonists (Cosen-Binker et al. 2003). In a later 
study of Binker et al. (2010), pancreatitis severity was greatly 
decreased by treating animals with an anti-TNF-α-antibody 
which diminished all inflammatory parameters, histopatho-
logical scores, and apoptotic/necrotic markers in stressed/
cerulein-treated rats. These animals, however, still developed 
a very mild form of this disease, and the authors concluded 
that the limited protection achieved in vivo was most likely 
due to multiple factors involved in pancreatitis development, 
some of which must act independently of TNF-α.
Our previous research revealed that compounds from 
the substituted 1,3,4-thiadiazines group affect the course 
of experimental AP (Rantsev et al. 2013). Administration 
of the tested compounds significantly changed the systemic 
inflammatory response pattern on the first experimental 
day, reduced mortality rates and lowered cytokine levels 
(Rantsev et al. 2013). Similar changes were observed after 
the administration of these compounds in experimental 
myocardial infarction (Sarapultsev et al. 2014). The com-
mon dominant role of inflammation and stress reaction in 
both pathogeneses indicates that stress modulation is a key 
mechanism in 1,3,4-thiadiazine action.
This was confirmed by stress immobilization experiments 
where the substituted 1,3,4-thiadiazine L-17 lowered reac-
tion to stress (Sarapultsev et al. 2015) and by the results 
of pharmacological evaluation (Sarapultsev et al. 2016). 
A  report demonstrated that L-17 combined adrenergic, 
cholinergic and serotonin blockers and exerted its best effect 
in a similar concentration range to that used for the atypical 
antipsychotic agent Eglonyl (sulpiride) for antidepressants 
such as amitriptyline and in the alpha-blocker pyrroxanum 
(Sarapultsev et al. 2016). These promising research results 
on the course of experimental AP and the ability to lower 
reaction to stress by the proven antistress/neuroleptic action 
of this compound have inspired this extended study’s aim: 
to investigate the therapeutic mechanisms of L-17, with 
a histological, haematological, biochemical and immuno-
histochemical evaluation and an assessment of circulating 
cytokine levels.
Material and Methods
Test compound
2-morpholino-5-phenyl-6H-1,3,4-thiadiazine hydro-
bromide (compound L-17) (Reaxys RN=14755889, CAS 
NUMBER 193208-23-0) from the group of substituted 
1,3,4-thiadiazines studied in these experiments has proven 
a  biological effect (Rantsev et al. 2013; Sarapultsev et al. 
2014, 2015, 2016). The lethal dose of L-17 (LD50) is 434 mg/
kg (by weight), and the compound is a registered invention 
(United States Patent No 6313111 of 6 November 2001, PCT 
RF Patent No 2259371 of 27 August 2005).
Animal preparation
The experiment was performed on healthy, sexually mature, 
and nonlinear albino male rats quarantined in the vivarium 
of the Institute of Immunology and Physiology of the Ural 
Division of RAS (Ekaterinburg, Russia). The animals showed 
no symptoms of any disease, and all were kept under the same 
conditions and fed according to a customary schedule. All 
experimental procedures with the animals were approved 
by the Institute of Animal Care and Use Committee at the 
Institute of Immunology and Physiology of the Ural Divi-
sion of RAS (pan-1-04-2015) and performed in accordance 
with Directive 2010/63/EU for the protection of laboratory 
animals, the APS Guiding Principles in the Care and Use 
of Vertebrate Animals in Research and Training, and the 
Laboratory Practice Regulations of RF (Ministry of Public 
Health Order No. 267 from 19. 06. 2003).
Experimental model of acute pancreatitis
The experimental model used was described in a  previ-
ous work (Rantsev et al. 2013) and is relevant to the most 
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common clinical form of AP developing in cholelithiasis. 
According to the literature, experimental models of AP can 
be divided into in vivo (non-invasive and invasive) and ex 
vivo models (Ceranowicz et al. 2015). The onset, develop-
ment, severity and extent of AP as well as the mortality vary 
considerably between these different models (Ceranowicz et 
al. 2015). The invasive in vivo ligation model used in a study 
(Rantsev et al. 2013) causes a clinical syndrome resembling 
the multiple organ failure observed in humans (pancreatic 
necrosis and haemorrhage, white cell infiltration and mul-
tiple microthrombi (Vasilescu and Tasca 1991) and mimics 
the acute pancreatitis seen after Polya gastrectomy (Su et 
al. 2006).
Concise description of the technique: under general an-
aesthetic, a midline 2–3 cm laparotomy was performed along 
the Sergeant’s white (Hunter’s) line to reduce blood loss. 
The duodenum, mesogaster and part of the stomach were 
delivered, and transillumination of duodenum mesentery 
elements was performed to visualize details, including the 
affected elements (pancreatic gland ducts and duodenum 
marginal vessel). Isolated ligation of the main pancreatic duct 
was then performed 0.5 cm from the duodenum wall. The 
thickness of the filaments was 8.0 (0.040–0.049 mm) on the 
non-traumatic needle of the circular section. The laparotomy 
wound was sutured. After the first 24 hours, the animals only 
received water, and they were switched to habitual eating 
patterns after 48 hours. Ten minutes after experimental AP 
modelling, the animals resumed preoperative behavioural 
reactions. After evaluating behavioural patterns over 24 
hours, there were no detectable peculiarities in behavioural 
responses, and the animals were active and responded read-
ily to photoirritation and acoustic stimulation. There were 
no symptoms of respiratory failure, malnutrition or altered 
liquid consumption.
Experimental protocol
The trial was performed on fifty 8-to-16-week old (mean 
age) male Wistar rats with an average body weight of 200-
300 g (Table 1). Animals of the same age provided at the 
same time by the rat farm formed the trial and the reference 
sets. The animals were randomly divided into experimental 
groups to obtain statistically reliable results, and groups A–D 
were established: (1) Group A comprised 5 intact animals 
with an average body weight of 274 g; (2) experimental pan-
creatitis Group B contained 20 animals with an average body 
weight of 250 g divided into Groups B1 and B7, marking the 
day 1 and day 7 end-points of the experiment, with 10 ani-
mals in each Group; (3) Group C comprised 5 intact animals 
with an average body weight of 244 g, and they were injected 
intraperitoneally with 40 mg/kg of L-17 compound and (4) 
Group D comprised 20 animals with induced experimental 
acute pancreatitis; their average body weight was 256 g, and 
these animals were injected intraperitoneally with 40 mg/kg 
of L-17 compound an hour after surgery. A 40 mg/kg dose 
of L-17 compound was then repeatedly injected as often as 
once every 24 hours. Group D was divided into sub-Groups 
D1 and D7 to mark experimental-day end-points.
The individual experimental procedure was as follows: 
after overnight fasting, the rats were anaesthetized with 
ether, and experimental acute pancreatitis was performed; 
diazepam (2.5 mg/kg) was used to reduce the dose of general 
anaesthetic and for smoother induction and recovery, and 
all rats were anaesthetized with ether at the experimental 
endpoints and euthanized. 
Histological and laboratory testing
Blood was collected in at least 5 ml volumes in separate 
tubes for different studies directly from the abdominal aorta 
without contact with surrounding tissues. 
Biochemistry study
Biochemical testing was performed by a DU-800 spectro-
photometer (Beckman Coulter Int S.A., Switzerland). 
For biochemical analysis, 3 ml of blood was obtained from 
the tail vein for subsequent centrifugation and serum separa-
tion. The serum activity of alanine aminotransferase (ALT) 
and aspartate aminotransferase (AST) was investigated at 
the endpoints of the experiment (reagent kits ALT 01/11 and 
AST 01/11, “Vital Development Corporation”, Saint- Peters-
Table 1. Experimental protocol
Group Group description Number of animals Mortality
A Intact animals 5 0
B-1
Experimental AP
10 10% (1 animal)
50% (5 animals)B-7 10
C L-17 compound administration 5 0
D-1
Experimental AP + L-17 compound
10 0
30% (3 animals)D-7 10
AP, acute pancreatitis.
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burg, Russia) using an IM_MAGE 800 Immunochemistry 
System (Beckman Coulter Int S.A., Switzerland).
Serum bilirubin: the serum total and direct bilirubin 
were measured according to (Rutkowski and DeBaare 1966). 
Serum indirect bilirubin was obtained by subtracting the ob-
tained direct bilirubin level from the obtained total bilirubin. 
The level of creatinine in the serum was measured according 
to Heinegård and Tiderström (1973).
Immunohistochemical study
Two millilitre samples of arterial blood were collected and 
centrifuged for 10 min at 1,000 × g. The plasma portion 
was collected, and the sample was stored at –70°C until all 
plasma samples were obtained. ELISA analysis for plasma 
cytokine levels was performed with commercially available 
test kits following manufacturer instructions (Rat IL-10 
Platinum ELISA BMS629/BMS629TEN, Rat TNF-α Plati-
num ELISA BMS622/BMS622TWO/BMS622TEN, Rat IL-6 
Platinum ELISA BMS625/BMS625TEN, Rat IL-1β Platinum 
ELISA BMS630/BMS630TEN; Thermo Fisher Scientific 
Inc., Waltham, MA, U.S.A.). All samples were analysed in 
duplicate, and ELISA testing was performed by a Personal 
LAB Adaltis immunoassay analyser (Adaltis S.r.l., Guidonia 
Montecelio, Italy).
Haematological examination
All blood samples were taken with plastic test tubes contain-
ing K3-EDTA as a coagulant, and peripheral samples from 
experimental and control Group rats were examined by 
a Celly 70 18 parameter veterinary haematological analyser 
(Biocode-Hycel, Paris France). 
Histology and morphometric studies
Material preparation: histological tissue processing was 
performed with a Leica EG 1160 automatic tissue proces-
sor (Leica Mikrosysteme, Nussloach, GmbH). The tissue 
was dehydrated in a series of baths containing increasing 
concentrations of ethanol, treated with chloroform and 
embedded in paraffin. The formation of paraffin blocks with 
tissue samples was conducted using a Leica EG1160 v 4.1 
filling station, and 3–5 μm-thick histological sections were 
then cut by a Leica SM2000R sledge.
Analysis of the microscopy samples was performed by 
Leica DM2500 microscope connected to a Leica DFC420 
video recorder and a  PC (Leica Mikrosysteme, Wetzlar, 
Germany). The cells were counted, and the blood vessel 
diameters were measured by Leica application suite v.4.10.0 
image analysis software. 
Cellular structures were studied with a microscope objec-
tive magnification of 100 in 20 fields of vision followed by 
re-calculation for 1 mm2. The microcirculatory bloodstream 
vessel diameter was measured at least 20 separate times for 
each section. Arithmetic mean values were calculated for the 
data collected, and this was followed by further statistical 
analysis. Morphometric studies were performed with Leica 
application suite v.4.10.0 image analysis software, Leica 
Microsystems.
Statistical analysis
Statistical investigation utilized the Student’s t-test and a non-
parametric Mann-Whitney test with the Statistica Six Sigma 
Release  7 computer program used for data mathematical 
processing. All data are expressed as the mean ± SD, with 
p = 0.05 considered statistically significant.
Results
Mortality
A significant experimental reduction in mortality with ad-
ministration of L-17 compound was observed (10% vs. 0% 
on the 1st experimental day and 50 vs. 30% on the 7th day 
in Groups B and D, respectively), with multiple organ failure 
as the main cause of death in Group B animals (Table 1).
Macroscopic intra-operative pattern
Cardinal differences in the macroscopic picture for Groups 
B-7 and D-7 appeared on the seventh experimental day. 
Group B-7 animals displayed progressive pancreatic necrosis 
and suppurative complications, whereas Group D-7 had an 
aborted inflammatory process with no abdominal cavity 
Figure 1. Pancreas of intact animals. (H&E staining, magnifica-
tion ×200). 
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Figure 2. Pancreas of in-
tact animals. A. Group B-1, 
1st day. Necrosis of acinar 
structures of the exocrine 
part of the pancreas without 
a  pronounced cellular reac-
tion. B. Group D-1, 1st day. 
Acute pancreattis. 1st day 
on the background of L-17 
compound administation. 
Necrosis of acinar structures 
with signs of exudative reac-
tion and diffuse leukocyte 
infiltration. C. Group B-7, 
7th day. Focal necrosis of 
the acinar structures of the 
exocrine part of the pancreas, 
the formation of granulations 
and the signs of polymorpho-
nuclear leukocytes infiltra-
tion and ductal proliferation. 
D. Group D-7, 7th day. Loose 
connective tissue with func-
tionally active fibroblasts 
and a  significant number 
of young collagen fibers. 
(H&E staining, magnifica-
tion ×200).
effusion and no visual steatonecrosis or fibrinous overlap 
and with only minor swelling and infiltration noted in the 
pancreatic tissue.
Microscopic histological intra operative picture
The microscopic histological intra-operative picture mir-
rored the observed macropicture.
Microscopic histological intra-operative picture in acute 
pancreatitis
The pancreas of Group A animals is presented in Fig. 1. In 
Group B-1 animals the necrotic foci of destroyed acinar 
structures in the exocrine part of the gland without a pro-
nounced cellular reaction were observed (Fig. 2. Part 1) 
while on the 7th day of experimnt focal necrosis of the 
acinar structures of the exocrine part of the pancreas, the 
formation of granulations and signs of polymorphonuclear 
leukocyte infiltration and ductal proliferation were detected 
(Fig. 2. Part 3).
Microscopic histological intra-operative picture of acute 
pancreatitis with L-17 compound administration
On the 1st day of L-17 compound administration, in ani-
mals of D-1 Group signs of acinar structures necrosis with 
exudative reaction and diffuse leukocyte infiltration were 
observed (Fig. 2. Part 2). Histological examination of Group 
D-7 animals revealed the presence of loose connective tissue 
with functionally active fibroblasts and a significant number 
of young collagen fibres (Fig. 2. Part 4).
Peripheral blood changes in the animals of the experi-
mental group 
The pattern of peripheral blood changes in Group A-D 
experimental animals is presented in Table 2. 
A
C
B
D
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Pattern of peripheral blood changes due to AP
Our results determined an increase in total haemoglobin 
and the haematocrit index in Group B-1 on the first day of 
the experiment. Similarly, there was a  significant 2.5-fold 
increase in granulocyte number and a decrease in leuko-
cytes, lymphocytes and platelets compared with the intact 
Group A animals, but no changes in monocytes were ob-
served. However, the granulocyte number increased 3-fold 
(up to 7.45 ± 1.67) for Group B-7 on the 7th experimental 
day together with a significant increase in leucocytes (9.75 
± 1.76), lymphocytes (1.86 ± 0.17) and blood monocytes 
(0.44 ± 0.11).
Pattern of peripheral blood changes due to AP with the 
administration of L-17 compound
While the administration of L-17 compound to Group 
C  produced no significant peripheral blood changes, the 
following changes were recorded for Group D1 on the first 
experimental day: erythropoiesis manifested with increased 
total erythrocytes and haemoglobin, and there was also 
a significant increase in total thrombocytes (689.2 ± 29.28) 
compared with intact animals. However, no significant dif-
ferences in values were observed on the 7th experimental 
day for the Group D-1 experimental group with L-17 ad-
ministration.
Comparison of peripheral blood changes in animals with AP 
with and without L-17 compound administration
(a) Granulocytes: on the first experimental day, the num-
ber of granulocytes in Group D-1 blood was significantly 
higher than in Group B-1 animals, at 2.57 ± 0.62 vs. 1.85 
± 0.64. While this cell number slightly increased on the 7th 
end-point day in experimental pancreatitis animals with L-17 
administration, the number increased 3-fold from the first 
experimental day values to 7.45 ± 1.67 in animals lacking 
L-17 administration.
(b) Lymphocytes: the number of lymphocytes in Group 
D-1 animals with L-17 administration doubled compared 
with those in the control group on the first experimental 
day at 0.92 ± 0.77 vs. 0.45 ± 0.23).
(c) Leucoytes: while there was a significant increase in the 
leucocyte number (1.86 ± 0.17) in Group B-7 animals over 
Group B-1 by the 7th experimental day, both administration 
groups D-1 and D-7 L-17 recorded no significant changes 
in that week.
Morphometric study of the pancreas
No structural changes were detected in the Group  A 
and C pancreas; therefore, the morphometric pancreatic tis-
sue study was limited to experimental Group B and D. This 
study compared the inflammation severity and the nature of 
the inflammatory infiltrate in the inflammatory dynamics of 
experimental pancreatitis; the results are listed in Figure 3.
Pattern of morphometric parameter changes in AP
The morphometric study revealed that the Group B  ex-
perimental pancreatitis animals had a significant increase 
Table 2. Pattern of peripheral blood changes in animal experimental groups
Group Erythrocytes(1012/l)
Hemoglobin
(g/l)
Hematocrit
(%)
Leucocytes
(109/l)
Granulocytes
(109/l)
Lymphocytes
(109/l)
Monocytes
(109/l)
Thrombocytes
(109/l)
A 6.92 ± 0.5 127.2 ± 6.84 33.2 ± 2.72 4.1 ± 1.43 0.7 ± 0.35 1.4 ± 0.7 0.09 ± 0.04 956.7 ± 98.7
C 6.8 ± 0.13 132 ± 3.12 34 ± 1.2 3.7 ± 1.0 0.6 ± 0.4 1.2 ± 0.6 0.08 ± 0.05 925 ±  8.4
B-1 6.84 ± 0.34 143.33 ± 4.19* 37.92 ± 1.58* 2.3 ± 0.31*,# 1.85 ± 0.64*,# 0.45 ± 0.23* 0.09 ± 0.04* 689.2 ± 29.28*,#
D-1 7.16 ± 0.78* 135.73 ± 2.09* 37.57 ± 4.93 3.65 ± 1.16 2.57 ± 0.62 0.92 ± 0.77 0.13 ± 0.1 819.21 ± 65.93*
B-7 6.21 ± 0.83 113.67 ± 9.46 32.17 ± 2.65# 9.75 ± 1.76# 7.45 ± 1.67# 1.86 ± 0.17 0.44 ± 0.11# 1067.5 ± 318.37
D-7 6.28 ± 0.58 113.73 ± 2.28 30.51 ± 0.92 4.63 ± 2.78 3.22 ± 1.64 1.16 ± 0.9 0.13 ± 0.09 1097.11 ± 51.31
* p < 0.05 the first vs.seventh day; # p < 0.05 groups without treatment vs. groups with treatment on the same day of the experiment.
Figure 3. Results of morphometric study of the pancreas. 
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in granulocyte number in pancreatic tissue on the 7th 
experimental day (20.76 ±  3.15) compared with the first 
day (12.96 ±  3.91). While the number of monocytes and 
lymphocytes did not differ in Groups B-1 and B-7, plasmo-
cytes were significantly lower in Group B-7 on the 7th day of 
experimental pancreatitis (0.66 ± 0.76) than in B-1 animals 
on the first day (1.0 ± 0.75).
Pattern of changes in morphometric parameters in AP with 
L-17 compound administration
The morphometric analysis determined no significant 
changes in quantitative infiltrate composition between the 
1st and 7th days of the experiment. 
Comparison of morphometric parameter changes in  
animals with AP with and without L-17 compound 
administration
An important difference occurred in the granulocyte number 
of the pancreatic tissue of the experimental group on the first 
experimental day. Here, the granulocyte number for Group 
D-1 with L-17 administration was significantly lower than 
in control Group B-1 (8.6 ± 4.6 vs. 12.96 ± 3.91). Moreo-
ver, the number of granulocytes on the 7th experimental 
day significantly increased compared with the first day in 
Group B  animals with induced acute pancreatitis but no 
L-17 administration. This indicates increased inflammatory 
response activity. In addition, Group D animals with L-17 
administration had a tendency to decrease granulocytes over 
time (7.75 ± 6.2 vs. 8.6 ± 4.6).
The change in pancreatic monocyte and lymphocyte 
numbers had a fundamentally different character; the number 
of monocytes in Group B-1 animals was significantly lower 
than those in Group D-1 (1.7 ± 0.78 vs. 3.2 ± 31) on the first 
experimental day, and a similar ratio was maintained on the 
7th end-point day in Groups B-7 and D-7 (1.82 ± 0.53 vs. 3.3 
± 2.4). While similar changes were observed in lymphocyte 
number at 2.02 ± 0.84 vs. 9.1 ± 4.6 on the first day and 2.68 
± 1.09 vs. 7.6 ± 5.9 on the seventh day, plasmocyte pancreatic 
infiltration in B-Groups was significantly higher than in the 
D-groups at 1.0 ± 0.75 vs. 0.6 ± 0 87 on the first day and 0.66 
± 0.76 vs. 0.4 ± 0.67 on the seventh day.
Biochemical study results
Figure 4 highlights that the most informative biochemi-
cal marker reflecting the severity of body reaction to the 
primary pancreatic lesion was pancreatic amylase, where 
the blood amylase level was twice high in Group B-1 than 
in D-1.
Pattern of cytokine response in experimental group 
animals
The results of the immunohistochemical study are shown 
in Figure 5.
Pattern of cytokine response in induced acute pancreatitis
The results of animals with induced acute pancreatitis on 
the first day showed a significant increase in circulating cy-
tokine levels; the TNF-α level quadrupled, IL-1β increased 
34 times, IL increased 6-11 times and IL-10 increased 373 
times compared with intact animals. While the TNF-α levels 
did not change by the 7th experimental day, the remaining 
cytokine levels decreased compared with the first day; IL-1β 
decreased 5 times (77.23 ± 8.5 in Group B-7 vs. 545.5 ± 441.2 
in Group B-1), and IL-10 decreased tenfold (66.24 ± 8.5 in 
Group B-7 vs. 746.3 ± 135.9 in Group B-1).
Figure 4. Results of biochemical study. Amylase ALT, AST (U/l); 
Bilirubin, Creatinine (mmol/l).
Figure 5. Levels of blood cytokines on the first and seventh day 
of experiment.
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Cytokine response pattern in AP with compound L-17 
administration
A significant increase in cytokine level was noted on the first 
experimental day for Groups D-1 and D-7 with compound 
L-17 administration; TNF-α increased 9 times compared 
with intact animal values (to 131.6 ± 32.2), the IL-1β and IL-6 
tripled (54.45 ± 4.1 vs. 16.6 ± 4.59 and 58.48 ± 2.07 vs. 19.67, 
respectively), and IL-10 increased 26 times (61.05 ± 57.34 
vs. 2.28 ± 305). However, by the 7-day end-point there was 
a significant increase in the TNF-α level from 44.73 ± 29.8 
to 131.6 ± 32.2, but the remaining cytokine levels did not 
change from the first day.
Comparison of cytokine response in animals with AP with 
and without the L-17 compound administration
The results here show that while levels of all cytokines in-
creased in induced experimental acute pancreatitis Groups 
B and D, the rise in cytokine level was less than in Group 
D when the compound L-17 was administered. In contrast, 
the reverse situation was observed for TNFa on the first ex-
perimental day (53.23 ± 48.0 in Group B-1 vs. 131.6 ± 32.2 
in Group D-1).
Reactivity index
Given the significant fluctuation in the cytokine levels, to 
understand the meaning of the observed changes, a calcu-
lation of the reactivity index (RI) and reactivity coefficient 
(RC) by E.Yu. Gusev was conducted (Gusev et al. 2008; 
Zotova et al 2016). The calculation of the RI and RC pa-
rameters and their comparison with characteristics of the 
inflammatory process illustrated that L-17 administration 
decreased the inflammatory activity from the critical level 
of systemic inflammation (SI), which is the “prognosis zone” 
for the development of lethal complications to the condi-
tionally critical level, typical for marginal manifestations of 
SI or for the hyperactive form of “classical” inflammation 
(Gusev et al. 2008; Zotova et al 2016).
Discussion
Changes in cellular content
Changes in granulocyte number
The most interesting finding from the comparison of granu-
locyte number in the experimental Group B and D was the 
significant increase in granulocytes in animals of Groups 
B between the 1st and 7th experimental days contrasted with 
no change in cell number in the L-17-administered animals 
in this period. This revealed the ability of L-17 to prevent 
granulocytosis and SI in acute pancreatitis.
A reduction in granulocytosis may prevent SI develop-
ment as neutrophils can regulate the size and outcome of 
the inflammatory response through the uptake and release 
of cytokines and chemokines (Basran et al. 2013). Neutro-
phils therefore play a significant role in the development of 
both local and widespread acute pancreatitis (Basran et al. 
2013; Williams and Chambers 2014). Moreover, Leppkes et 
al. (2016) report that intraductal neutrophil-rich aggregates 
are one of the most important links in local pancreatic in-
flammation, where their formation and consequent ductal 
occlusion orchestrates the focal appearance of pancreatitis 
(Leppkes et al. 2016).
Many authors have described observing a  decrease 
in neutrophil number leading to decreased pancreatitis 
inflammatory intensity, with reduced pancreatic trypsin-
activation peptide and serum amylase levels and the pre-
vention of secondary damage to other organs, including the 
lungs (Konturek et al. 1998; Frossard et al. 1999; Abdulla et 
al. 2011). Moreover, Fazal et al. (2000) report that intestinal 
bacterial translocation is most likely related to increased 
infiltration of activated neutrophils into intestinal tissue 
because the release of neutrophil products such as the 
superoxide anion can cause intestinal damage, whereas 
neutrophil depletion reduces bacterial translocation. Thus, 
the ability of L-17 to prevent increased granulocytosis 
in the blood explains the absence of SI in experimental 
animals (Group D). 
Our results from comparing the granulocyte levels in 
blood and in the tissue homogenate from pancreatic inflam-
mation foci are therefore of great interest (Figure 3). They 
revealed that the blood granulocyte levels in Group B-1 
animals were lower than in Group D-1 on the first experi-
mental day, but the tissue homogenate granulocyte levels 
were significantly higher in Group B-1 than in Group D-1. 
This is explained by the decreased granulocyte infiltration to 
inflammatory foci following L-17 administration. However, 
the detected increase in granulocyte numbers in the inflam-
matory foci in Group B-7 animals on the 7th experimental 
day and this absence in Group D-7 animals demonstrate 
the inhibition of a  progressive inflammatory reaction by 
preventing an excessive accumulation of neutrophils in the 
inflammatory foci. 
Data from the literature offer stress reaction development 
as one reason for the increased neutrophil levels (Bob et al. 
2010), and Engler et al. (2004) report that recurrent exposure 
to the stressor was associated with cell mobilization and 
increased myelopoiesis in bone marrow. This is paralleled 
by neutrophil and monocyte accumulation in the circulation 
and spleen (Engler et al. 2004). Moreover, a stress-induced 
rise in plasma corticosterone levels leads to an increased 
release of polymorphonuclear leukocytes from the bone 
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marrow, with an accompanying delay in their apoptosis 
and a significant decrease in numbers and percentages of 
lymphocytes (Nakagawa et al. 1998). 
Stress also induces endotoxaemia in tissue injuries 
primarily by increasing the intestinal barrier (de Punder 
and Pruimboom 2015). Bacterial toxins (LPS) that enter 
the bloodstream, in turn, stimulate neutrophilia (Yakovlev 
2003).
The proven ability of thiadiazine compounds such as L-17 
to increase resistance to stress (Sarapultsev et al. 2015) ex-
plains the observed decrease in neutrophilia and neutrophil 
count in inflammatory foci and the revealed inhibition of SI.
Changes in leucocyte and monocyte numbers
The principal difference in lymphocyte and monocyte 
numbers in experimental Group B  and D  animal blood 
and tissue requires explanation. Despite the significant 
increase in Group B-7 blood monocytes, the infiltration 
of monocytes in the pancreatic tissue of Group B-1 and 
B-7 animals was significantly lower than in the D-Groups 
throughout the experiment (Figure 3). Here, the observed 
increase in monocytes/macrophages in inflammation foci 
in L-17-administered animals undoubtedly decreased the 
magnitude of the inflammatory process and accelerated the 
onset of granulation formation because macrophages regulate 
all phases of wound healing and their major function is the 
absorption of apoptotic and necrotic cells in damaged tissue 
(Sindrilaru and Scharffetter-Kochanek 2013). Yeager et al. 
(2016) report that all of the described processes of tissue 
infiltration by neutrophils, their replacement by macrophages 
and macrophage differentiation are directly or indirectly 
regulated by glucocorticosteroids, and stress or almost any 
other threat to homeostasis causes increased plasma gluco-
corticoid levels (Yeager et al. 2016). Thus, the early increase 
in macrophage number in inflammatory foci in animals 
administered L-17 compound has the following effects: it is 
not only responsible for a reduction in the magnitude of the 
inflammatory reaction, as reduced macrophage infiltration 
causes delayed wound healing (van Amerongen et al. 2007; 
Mirza et al. 2009), but it is also an indirect sign of the changes 
that substituted thiadiazines induce in the stress response. 
In addition, the increased circulating monocytes in 
Group B  animal blood appears to be responsible for the 
generalization of inflammation processes because systemic 
inflammatory events in the early stages of acute pancreatitis 
are triggered by the activation of circulating monocytes but 
not T-cells, playing a central role (de Dios et al. 2002).
The significant difference in lymphocyte numbers in the 
blood and pancreas of experimental animals deserves special 
attention. Our results highlight that the number of lympho-
cytes in experimental Group B-1 blood on the first day did 
not differ from Group D-1 values in these first-day experi-
mental animals administered with L-17. However, on the 7th 
experimental day, blood lymphocytes significantly increased 
in Group B-7 animals but did not differ in Group D-7, and 
the tissue-infiltrating lymphocytes in Groups B-1 and B-7 
animals did not change during experimental progression 
but were significantly lower than in Groups D-1 and D-7.
The more rapid injury zone granulation and lack of 
purulent foci in L-17-administered D-1 and D-7 animals 
compared to those in Group B is explained by the different 
lymphocyte action mechanisms in blood and the injury 
area.
Figure 3 highlights that the significantly lower plasmocyte 
infiltration in inflammatory foci in Group D-1 compared with 
Group B-1 could quite well be beneficial. It is very important 
that plasmocytes can modulate immune and inflamma-
tory responses, not only by antibody production but also 
by their secretion of the TNF-α key inflammatory media-
tor. The resultant accumulation of plasma cells at inflamed 
sites may therefore promote a synchronized inflammatory 
process leading to the accumulation of extraordinary levels 
of locally produced, specific antibodies for certain antigens 
(Mallison et al. 1991). Hence, the significant decrease in 
plasmocyte infiltration of the inflammatory focus observed 
in Group D animals on the first day contributes to decreased 
severity of the inflammatory reaction.
Cytokines
A significant increase in circulating cytokine level in B-1 
animals was observed over the course of the experimen-
tal pancreatic necrosis compared with the normal values 
(Figure 5). The TNF-α increased 4-fold, IL-1β increased 
34-fold, IL-6 increased 11-fold and IL-10 increased up to 
373 times. This is typical in acute pancreatitis development, 
and it is described in both experimental studies (Dembinski 
et al. 2001; Ramudo et al. 2005; Zaheer and Zaheer 2005; 
Ceranowicz et al. 2008; Vinnik et al. 2011)and in clinical 
studies (Chen et al. 1999; Hirota et al. 2000). Moreover, 
high levels of interleukins can impede wound repair (Em-
ing et al. 2007); therefore, the decrease in cytokine levels 
with the increased macrophage number accelerating repair 
processes (Ceranowicz et al. 2008) observed in the study 
might be beneficial. 
Mortality and systemic inflammation
SI development in the Group B and D experimental animals 
was confirmed by the significant increase in cytokine levels on 
the first experimental day (Bone et al. 1997; Norman 1998). 
Signs of MODS (multiple organ dysfunction syndrome) and 
CARS (compensatory anti-inflammatory response syndrome) 
manifested in B-7 animals on the 7th experimental day as dif-
fuse leukocyte infiltration and abscess formation in the mesen-
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tery and peritoneum and in the appearance of steatonecrotic 
foci in the pancreatic tissue and accompanying peritonitis. 
The ability of L-17 compound to reduce inflammatory 
cytokine levels may explain the significant experimental re-
duction in mortality. Here, cytokine levels regulating inflam-
mation reflected the intensity of surgical stress, as in (Aosasa 
et al. 53). These levels consequently reflect the degree of SI 
influence on damage to the cells of internal organs, such as the 
pancreas. Therefore, the decreased IL-10 in Group D animals 
influenced CARS development, and this was confirmed by 
the absence of purulent foci and peritonitis on the 7th day.
A summary of our results (Figure 6) provides the conclu-
sion that the decrease in inflammatory reaction magnitude 
and prevention of abscess formation and peritonitis in ex-
perimental AP accompanied by SI was due to the ability of 
L-17 to reduce neutrophilia and neutrophil entry into the 
injury zone. Moreover, the accelerated regeneration was 
caused by the compound’s induced increase in macrophage 
and lymphocyte numbers in the damaged area. These mecha-
nisms were mediated by the reduction of proinflammatory 
and anti-inflammatory interleukin levels by L-17. However, 
increased interleukins and neutrophilia depend on the se-
verity of stress in tissue damage; hence, it is assumed that 
the major action mechanism of L-17 is anti-stress activity 
as previously described in the stress immobilization model 
(Sarapultsev et al. 2015).
Proposed mechanisms of action
The ability of substituted 1,3,4-thiadiazine compounds to 
lower stress reaction was previously described (Sarapultsev 
et al. 2015), and their ability to act on both serotonin and 
adrenergic systems has been proposed (Sarapultsev et al. 
2016).. Here, a singular synchronized-action on serotonergic 
and adrenergic systems, also seen in psychotropic drugs, 
significantly enhanced their therapeutic effect (Arnsten 
2004) because alpha-1 and serotonin (5HT2A) receptors 
are involved in the common phosphatidyl inositol/protein 
kinase C intracellular pathway via Gq proteins (Duman and 
Nestler 1995). 
Figure 6. The schematic representation of the L-17 compound effects in experimental acute pancreatitis. On the left part of the picture, 
the changes in the pancreatic tissue and the blood on the course of experimental acute pancreatitis are described: the rise of cytokines 
levels which led to the SI development and granulocytosis in the blood (accompanied with the increase in granulocyte numbers in the 
inflammatory foci on the 7th experimental day), which led to MODS, and CARS manifestation. On the right part of the picture, the 
changes in the pancreatic tissue and the blood on the background of L-17 compound administration are described: the increase in the 
lymphocyte and monocyte and the decrease in granulocyte numbers in the tissue on the 1st day. The decrease in the circulating cytokine 
levels on the 7th day with no signs of MODS and CARS.
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The described action mechanisms of L-17 are similar in 
effect to atypical antipsychotics (Sarapultsev et al. 2016), 
and this could explain its action on both the immune sys-
tem and inflammatory response. The literature records that 
antidepressant drugs frequently affect the dysregulated im-
mune response in depressed patients, mainly by improving 
the serum cytokine profile during therapy (Kenis and Maes 
2002; Janssen et al. 2010; Hannestad et al. 2011); this may 
result from their influence on cytokine release (Kubera et 
al. 2001a, 2001b, 2005). 
The change in monocyte numbers in tissues and blood 
from the administration of L-17 compound described in 
this article does not contradict the literature data which 
showed that antidepressant drugs modulate the peripheral 
humoral and cell-mediated immune responses through their 
action on lymphocytes and macrophages (reviewed in 62) 
(Maes 2011). Recent studies by Nazimek et al. (2016, 2017) 
also highlighted the direct impact of various antidepressant 
drugs on macrophages and showed that the administration 
of some antidepressants, including fluoxetine, venlafaxine 
and moclobemide, resulted in the suppression of humoral 
and cell-mediated immunity, with a reduction in the release 
of macrophage proinflammatory mediators and expression 
of antigen-presentation markers.
In general, compounds with similar biological effects to 
those used as antidepressants can down-regulate secretion 
of proinflammatory cytokines and up-regulate the release of 
anti-inflammatory cytokines. Nazimek et al. (2016) consider 
this a  mechanism of their anti-inflammatory effect (Na-
zimek et al. 2016, 2017), and it is also well described in the 
literature (Janssen et al. 2010; Kubera et al. 2011). Moreover, 
due to their impact on serotonin turnover, antidepressants 
may alter the immune response at the early stage of cell re-
cruitment to the inflammation site which depends, among 
other things, on platelet-derived serotonin (Nazimek et al. 
2016, 2017). This then decreases the neutrophil infiltration 
by the administration of L-17 compound described in the 
present study.
Conclusion
Given the data from the literature showing that the admin-
istration of antidepressant compounds to healthy people 
can modulate humoral and cell-mediated immune response 
and improve the course of a number of pathologies such 
as rheumatoid arthritis and encephalomyelitis on the one 
hand and the role of stress reaction in the pathogenesis of 
various diseases on the other, it is possible to cite Nazimek 
et al. (2016): “treatments with different antidepressant drugs 
possess significant translational potential and indicate that 
these drugs could be considered for application in complex 
therapeutic strategies dedicated to various disease”.
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